Tags
You are here: Home
Pfizer
Atlanta – The Center for Global Health
Down South - Atlanta has a healthy biosciences community with a rich mix of pharmaceutical, medical devices, diagnostic and medical supply companies; contract laboratory, preclinical and clinical research organizations; and world-class public and private institutions and universities. Atlanta's Bioscience Cluster more22.12.2011Pharma Asks The Money Question Earlier For New Drugs
GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the global healthcare system will pay for it. more03.11.2011Global Pharma to Pump Cash Into Russia
Viiv Healthcare, a GlaxoSmithKline and Pfizer joint venture, will start manufacturing HIV medicines in Russia in partnership with local drugmaker Binnopharm. Agreeing a local partnership is a way for international drug companies to secure guaranteed sales in Russia, which wants to reduce dependence on imported drugs. Global drugmakers have pledged at least $1 billion in investments in Russian manufacturing, packaging and research and development. more
Peter Pollak on the World of Fine Chemicals
In his book "Fine Chemicals - The Industry and the Business," Dr. Peter Pollak provides a comprehensive view on one of the most challenging segments of the modern chemical industry, and a practical guide for succeeding in the multibillion dollar fine chemicals business.more
The World Of Biosimilars
Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade. True to a point, but dynamic change for some is usually accompanied by significant opportunity for others. This is the "double-edged sword" paradox of the biosimilars market.In simple terms, biosimilars are the biotech industry's version of chemical generics. more
The Latest From ChemistryViews
CHEManager Europe Online is proud to share some of the interesting stories our colleagues at ChemistryViews have been working on for you. ChemistryViews is a platform that presents top-quality information from ChemPubSoc Europe, an organization of 16 chemical societies in continental Europe, publishing world-leading journals such as "Chemistry - A European Journal." Click and enjoy! more
Pharma Sourcing from India and China
India and China are being discovered by more companies as ideal place for pharma sourcing. These two countries continue to be the chosen destinations for a pharmaceutical industry hungry to lower research, development and manufacturing costs without sacrificing quality. While the growth of clinical research and other contract development services in India and China has tended to occupy the news headlines, the most significant part of this growing industry involves the manufacturing of active pharmaceutical ingredients (API) and finished drugs (FD). more
Patent Cliff To Intensify in the U.S. in 2011
Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic downturn. Drug developers have also contended with expanding government efforts to contain healthcare cost burdens during the past year. more
Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch
Becoming Nimble - It's no secret that Big Pharma is facing some of the biggest changes in the history of the industry. The looming patent cliff is now forcing companies to reexamine the way they do business from the ground up: According to IDC Health Insights, between now and 2012, 19 of the industry's blockbuster drugs will come off patent, for approximately $60 billion in annual industry revenue. more
Proper Integration of PAT and Process Automation Vital for Going Green
Facing Challenges - In today's world, the pharmaceutical and chemical industries face major challenges including globalization, environmental regulation, and shortening product life cycle. Meeting these challenges has required the development of innovative technologies and alternative approaches geared towards reducing costs and improving the environmental and economical profile of chemical processes. Breakthroughs in process operations and modeling have been necessary for achieving energy and material efficiency gains. more- Legal
- Help
- Participate
- Related Publications